Xuefei Yu

In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer

Jiang-Jiang Qin, Xuhang Zhu, Xuefei Yu, 2022, Frontiers in Pharmacology.

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer

Jinyun Dong, Xuefei Yu, Jiangjiang Qin, 2022, Frontiers in Pharmacology.

Structures of the endogenous peptide- and selective non-peptide agonist-bound SSTR2 signaling complexes

Qiaojun He, C. Mao, Yan Zhang, 2022, Cell Research.

IL-17D affects the chemokines and chemokine receptors of intestinal epithelial cells under hyperoxia.

Dongyan Liu, Xuefei Yu, Tianming Li, 2022, International immunopharmacology.

Development of simultaneous interaction prediction approach (SiPA) for the expansion of interaction network of traditional Chinese medicine

Wei Ji, Mengjie Rui, Siqi Wang, 2020, Chinese Medicine.

Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer

Xiao Zhao, Guangna Liu, Minghua Ge, 2022, Advanced science.

A Strategy for the Effective Optimization of Pharmaceutical Formulations Based on Parameter-Optimized Support Vector Machine Model

Chun-lai Feng, Mengjie Rui, He-Gang Chen, 2022, AAPS PharmSciTech.